These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3781424)

  • 1. On the role of pharmacokinetics in integrating results from in vivo and in vitro studies.
    Gillette JR
    Food Chem Toxicol; 1986; 24(6-7):711-20. PubMed ID: 3781424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic factors governing the steady-state concentrations of foreign chemicals and their metabolites.
    Gillette JR
    Ciba Found Symp; 1980; 76():191-217. PubMed ID: 6161761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human hepatic cell cultures: in vitro and in vivo drug metabolism.
    Gómez-Lechón MJ; Donato T; Ponsoda X; Castell JV
    Altern Lab Anim; 2003; 31(3):257-65. PubMed ID: 15612868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of induction of cytochrome P-450 enzymes on the concentration of foreign compounds and their metabolites and on the toxicological effects of these compounds.
    Gillette JR
    Drug Metab Rev; 1979; 10(1):59-87. PubMed ID: 118860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic stability for drug discovery and development: pharmacokinetic and biochemical challenges.
    Masimirembwa CM; Bredberg U; Andersson TB
    Clin Pharmacokinet; 2003; 42(6):515-28. PubMed ID: 12793837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conceptual underestimation of the total body clearance by the sum of clearances of individual organs in physiologically based pharmacokinetics.
    Berezhkovskiy LM
    J Pharm Sci; 2012 Dec; 101(12):4660-5. PubMed ID: 23001916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Criticism of pharmacokinetic clearance concepts.
    Keller F; Schoole J
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):563-8. PubMed ID: 6654532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurate Estimation of In Vivo Inhibition Constants of Inhibitors and Fraction Metabolized of Substrates with Physiologically Based Pharmacokinetic Drug-Drug Interaction Models Incorporating Parent Drugs and Metabolites of Substrates with Cluster Newton Method.
    Yoshida K; Maeda K; Konagaya A; Kusuhara H
    Drug Metab Dispos; 2018 Nov; 46(11):1805-1816. PubMed ID: 30135241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advances and related issues in the use of in vitro methods to predict metabolic clearance rate of new drugs].
    Zhang Q; Wang GJ
    Yao Xue Xue Bao; 2007 Oct; 42(10):1023-8. PubMed ID: 18229605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationalizing underprediction of drug clearance from enzyme and transporter kinetic data: from in vitro tools to mechanistic modeling.
    Galetin A
    Methods Mol Biol; 2014; 1113():255-88. PubMed ID: 24523117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and promises.
    Miners JO; Knights KM; Houston JB; Mackenzie PI
    Biochem Pharmacol; 2006 May; 71(11):1531-9. PubMed ID: 16455060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro methods to study the interplay of drug metabolism and efflux in the intestine.
    Siissalo S; Heikkinen AT
    Curr Drug Metab; 2013 Jan; 14(1):102-11. PubMed ID: 22497570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical cytochrome p450 kinetics: implications for drug discovery.
    Tracy TS
    Drugs R D; 2006; 7(6):349-63. PubMed ID: 17073518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologically based approaches towards the prediction of pharmacokinetics: in vitro-in vivo extrapolation.
    De Buck SS; Mackie CE
    Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):865-78. PubMed ID: 18028030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
    Gómez-Lechón MJ; Castell JV; Donato MT
    Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human drug metabolism and the cytochromes P450: application and relevance of in vitro models.
    Venkatakrishnan K; Von Moltke LL; Greenblatt DJ
    J Clin Pharmacol; 2001 Nov; 41(11):1149-79. PubMed ID: 11697750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying biological activity in chemical terms: a pharmacology primer to describe drug effect.
    Kenakin T
    ACS Chem Biol; 2009 Apr; 4(4):249-60. PubMed ID: 19193052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro-in vivo extrapolation method to predict human renal clearance of drugs.
    Kunze A; Huwyler J; Poller B; Gutmann H; Camenisch G
    J Pharm Sci; 2014 Mar; 103(3):994-1001. PubMed ID: 24549735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of human pharmacokinetics - renal metabolic and excretion clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Nov; 59(11):1463-71. PubMed ID: 17976256
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.